Table of Contents
Thrombosis
Volume 2015, Article ID 414523, 6 pages
http://dx.doi.org/10.1155/2015/414523
Clinical Study

Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study

1Northwestern Memorial Hospital, 251 E. Huron Street, Chicago, IL 60611, USA
2Seton Northwest Hospital, 11113 Research Boulevard, Austin, TX 78759, USA
3University Medical Center Brackenridge, 601 East 15th Street, Austin, TX 78701, USA
4Seton Medical Center Williamson, 201 Seton Parkway, Round Rock, TX 78665, USA
5Seton Medical Center Austin, 1201 West 38th Street, Austin, TX 78705, USA

Received 28 August 2015; Accepted 6 December 2015

Academic Editor: Cees Vermeer

Copyright © 2015 Kirsten M. Roberts et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kirsten M. Roberts, Tamara B. Knight, Eimeira Padilla-Tolentino, Manasa Murthy, and Evan J. Peterson, “Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study,” Thrombosis, vol. 2015, Article ID 414523, 6 pages, 2015. https://doi.org/10.1155/2015/414523.